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Three mouse models of MYO5B recapitulate the features of
microvillus inclusion disease in neonatal mice, including the
formation of inclusions and loss of apical transporters in the
duodenum. The studies show the presence of a novel apical
membrane internalization pathway in neonatal duodenal
enterocytes.Abbreviations used in this paper: ATPase, adenosine triphosphatase;
DPPIV, dipeptidyl peptidase-4; E, embryonic day; KO, knockout;
MYO5B, myosin Vb; MVID, microvillus inclusion disease; NHE3,
sodium-hydrogen exchanger 3 protein; PCR, polymerase chain
reaction; pERM, phosphorylated ezrin-radixin-moesin; SEM, scanning
electron microscopy; TEM, transmission electron microscopy.
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http://dx.doi.org/10.1016/j.jcmgh.2015.11.009BACKGROUND & AIMS: Inactivating mutations in myosin Vb
(MYO5B) cause severe neonatal diarrhea in microvillus inclusion
disease. Loss of active MYO5B causes the formation of patho-
gnomonic inclusions and aberrations in brush-border enzymes.
METHODS: We developed 3 mouse models of germline,
constitutively intestinal targeted, and inducible intestinal
targeted deletion of MYO5B. The mice were evaluated for
enterocyte cellular morphology.
RESULTS: Germline MYO5B knockout mice showed early
diarrhea and failure to thrive with evident microvillus inclusions
and loss of apical transporters in the duodenum. IgGwas present
within inclusions. Apical transporters were lost and inclusions
were present in the duodenum, but were nearly absent in the
ileum. VillinCre;MYO5BF/F mice showed similar pathology and
morphologic changes in duodenal enterocytes. In contrast, when
MYO5B KO was induced with tamoxifen treatment at 8 weeks of
age, VillinCreERT2;MYO5BF/F mice developed severe diarrhea
with loss of duodenal brush-border enzymes, but few inclusions
were observed in enterocytes. However, if tamoxifen was
administered to 2-day-old VillinCreERT2;MYO5BF/F mice,
prominent microvillus inclusions were observed.
CONCLUSIONS: The microvillus inclusions that develop after
MYO5B loss show the presence of an unrecognized apical
membrane trafﬁcking pathway in neonatal duodenal enterocytes.
However, the diarrheal pathology after MYO5B loss is caused by
deﬁcits in transporter presentation at the apical membrane in
duodenal enterocytes. (Cell Mol Gastroenterol Hepatol
2016;2:131–157; http://dx.doi.org/10.1016/j.jcmgh.2015.11.009)
Keywords: Enterocyte Trafﬁcking; Brush Border; Rab11a;
Rab8a; Syntaxin 3; NHE3; MYO5B.icrovillus inclusion disease (MVID) is caused by
1–3Minactivating mutations in myosin Vb (MYO5B).
Neonates with MVID have severe life-threatening diarrhea
usually beginning in the ﬁrst week of life.4,5 Recent studies
using in vitro investigations in correlation with human
patient pathologic tissues have shown insights into the
possible pathophysiology of MVID.6–9 Our investigations
have shown that MYO5B interactions with Rab8a are
responsible for deﬁcits in microvillar structure and traf-
ﬁcking, whereas interactions between MYO5B and Rab11a
are responsible for microvillus inclusion formation.9
Importantly, we were able to show that microvillus
inclusions developed as a result of apical macropinocytosis.9
Although in vitro studies using MYO5B knockdown and
rescue in CaCo2 and CaCo2-BBE cells have identiﬁed
important mechanisms that putatively are involved in MVID
pathogenesis,3,7–9 important questions remain about the
signiﬁcance of microvillus inclusions to the diarrhea
phenotype and possible implications for treatment.
A recent publication reported a gene trap MYO5B
knockout mouse that showed duodenal microvillus
inclusions, but the pups died within 12 hours of birth,
limiting the pathology analysis.10 In addition, an inducible
intestinal MYO5B knockout mouse recently was reported to
develop microvillus inclusions within 4 days of MYO5B
loss.11 However, the sole reliance on adult mice to study a
neonatal disease may hamper direct interpretation of the
neonatal mechanisms involved in MVID. We now have
developed germline, intestinally targeted, and inducible
intestinal MYO5B knockout mice. Both germline MYO5B
knockout mice and VillinCre;MYO5BF/F mice showed
numerous microvillus inclusions in the proximal intestine,
Figure 1. Generation of germline MYO5B KO and
MYO5BF/F mice. (A) Schematic representation of the
knockout ﬁrst allele for MYO5B from the Knockout Mouse
Project is shown. This construct was used to generate
germline MYO5B KO mice by early termination of the
Myo5B transcription before exon 5. Mice harboring this
allele were mated to b-actin–FLP mice to also create
MYO5BF/F mice in which LoxP sites ﬂank exon 5. (B) PCR of
genomic DNA shows the different PCR product patterns
used to identify the genotype of a mouse. The 100-bp DNA
Ladder (New England Biolabs, Ipswich, MA) is shown in the
left lane of gels to denote PCR product size. The 500-bp
marker is indicated.
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Inclusions contained IgG, suggesting their derivation from
apical macropinocytosis involved with internalization of IgG
from maternal milk. However, although 8-week-old Villin-
CreERT2;MYO5BF/F mice induced with a single dose of
tamoxifen developed severe diarrhea within 48 hours, they
showed fewmicrovillus inclusions. Nevertheless, if 2-day-old
VillinCreERT2;MYO5BF/F mice received tamoxifen, they
developed prominent microvillus inclusions within 3 days.
Diarrhea in all 3 mouse models was well correlated with
losses in apical transporters in the proximal small intestine.
These results show that microvillus inclusions in MYO5B
knockout mice are not directly pathologic, but rather show
the presence of a specialized apical membrane processing
pathway in duodenal enterocytes during the neonatal period.
The predominance of pathology in the proximal small in-
testine suggests that interventions promoting distal intesti-
nal adaptation may represent an important strategy in the
treatment of MVID neonates.
Materials and Methods
All authors had access to the study data and reviewed
and approved the ﬁnal manuscript.
Construction and Validation of MYO5B
Deletion Mice
Embryonic stem cells harboring a knockout ﬁrst allele for
MYO5B (Figure 1A) were obtained from the Knockout Mouse
Project (KOMP, Davis, CA). Embryonic stem cells (CSD78985
clone B10) were injected into C57BL/6 mouse blastocysts by
the Vanderbilt Stem Cell Shared Resource. Ten chimeric male
mice (50%–80% chimeric) were produced and mated with
albino C57BL/6 mice to produce chimeric founders. One
chimera was responsible for germline transmission to black
offspring. The heterozygous mice from this line were mated
for 1 year and produced no viable homozygous offspring.
The mice therefore were crossed onto CD1 mice and after
3 generations crossed heterozygous mice gave birth to viable
homozygous knockout offspring.
To produce ﬂoxed allele mice, the MYO5Bþ/- mice were
bred with actin-FLP mice to derive MYO5Bﬂox/þ mice
(Figure 1A). The MYO5Bﬂox/þ heterozygotes were crossed to
produce homozygous MYO5Bﬂox/ﬂox mice (MYO5BF/F). The
MYO5BF/F mice then were crossed with both VillinCre and
VillinCreERT2 mice to produce VillinCre;MYO5BF/F targeted
intestinal MYO5B deletion mice and VillinCreERT2;MYO5BF/F
inducible intestinal knockout mice. The care, maintenance,
and treatment of animals in these studies followed protocols
approved by the Institutional Animal Care and Use Com-
mittee of Vanderbilt University.
DNA was isolated from mice tails using the DNeasy
Blood & Tissue Kit (Qiagen, Valencia, CA) according to the
manufacturer’s instructions. All genotyping was conﬁrmed
by speciﬁc polymerase chain reaction (PCR) with GoTaq
Green Master Mix (Promega, Madison, WI) (Figure 1B) using
the following PCR primer pairs: for Myo5B: MYO5BKO-F2,
5’-CTTGAGTTTGTTTAGTCTCTTGTCCCCTTTG-3’ and MYO5B
KO-R3, 5’-CCGCTGACTATGATGGATTGGTTCTTTTC-3’; forLacZ: LacZ-1, 5’-TGCCGCTCATCCGCCACAT-3’ and LacZ-2, 5’-
CACCGATCGCCCTTCCCAACAGT-3’; for VillinCre: 16775,
5’-GCCTTCTCCTCTAGGCTCGT-3’, 16776, 5’-TATAGGGCA-
GAGCTGGAGGA-3’, and oIMR9074, 5’-AGGCAAATTTTGGTG-
TACGG-3’; and for VillinCreERT2: 5’Cre, 5’-CGCGAACATCTT
CAGGTTCT-3’ and 3’Cre, 5’-CAAGCCTGGCTCGACGGCC-3’.
The following cycling parameters were used for Myo5B:
95C (3 min), 95C (30 s), 64C (30 s), 72C (45 s), and 72C
(5 min) with steps 2–4 repeated for 35 cycles. For LacZ and
VillinCre PCR, the annealing temperature of 62C was used,
and VillinCreERT2 PCR used 58C.
For validation of Myo5B messenger RNA loss, total RNA
was extracted from frozen duodenum samples using TRIzol
(Invitrogen, Carlsbad, CA). Total RNA (1 mg) was treated
with RQ1 RNase-free DNase (Promega), and then reverse-
transcribed using Superscript III reverse transcriptase
(Invitrogen) according to the manufacturer’s instructions.
PCR then was performed with Advantage Taq (Clontech,
Mountain View, CA) using the following primers: exon 4:
sense, 5’-CCTACGAGCAGCTGCCAATCTAC-3’ and exon
5: antisense, 5’-GACACCGTCTTGCCTGCTCCAGACTCTC-3’.
Cycling was performed at 95C for 15 seconds and at 68C
for 20 seconds, for 42 cycles.
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Fresh duodenum from each mouse was placed in 65C
lysis buffer (60 mmol/L Tris, pH approximately 6.8/10 mmol/
L EDTA/2% sodium dodecyl sulfate) directly after euthani-
zation. Samples were heated at 65C for 10 minutes and then
spun down for 10 minutes at 3600 rpm at 4C. Samples were
stored at -80C until time of use. At time of Western blot,
dithiothreitol (ﬁnal concentration, 0.12 mmol/L) was added
to each sample (50 mg of total protein), followed by 10 mi-
nutes of incubation at 65C. Samples were resolved on a 4%–
12% gradient Novex Bis-Tris gel (Invitrogen), and electro-
phoretically transferred onto Odyssey nitrocellulose mem-
branes (Li-Cor, Lincoln, NE). Membranes subsequently were
dried for 1 hour at room temperature, followed by blocking
with Odyssey TBS blocking buffer (Li-Cor) for 1 hour at room
temperature. Primary (rabbit anti-MYO5B, 1:500, Prestige cat.
HPA040902; Sigma, St. Louis, MO; and rabbit anti-VDAC1/
porin, 1:1000, cat. ab15895; Abcam, Cambridge, MA) and
secondary antibodies (IRDye 800CW donkey anti-rabbit IgG,
1:15000, cat. 925-32213; Li-Cor) were diluted in the blocking
buffer with 0.2% Tween-20. Membranes were visualized us-
ing the Odyssey Fc Imaging System (Li-Cor).
Determination of Mouse Weight and Stool
Water Content
Mice from all 3 mouse models were weighed at time of
euthanasia (at least n ¼ 3 for each group). To determine
stool water content, stool samples collected from the colon
(3 control mice and 3 MYO5B mice) were placed in pre-
weighed tubes and then the total stool weight was deter-
mined. The samples then were desiccated to dryness in a
Speedvac (Thermo Savant, Pittsburgh, PA) and the tubes
were reweighed. The differences in sample weights before
and after desiccation were determined and used to deter-
mine the percentage of stool water. Comparisons were
performed using a 1-tailed Mann–Whitney U test (Prism;
GraphPad, La Jolla, CA) with a P value of .05 or less.
Induction of VillinCreERT2;MYO5BF/F
Mice With Tamoxifen
Cre recombinase was activated in 8- to 10-week-old
VillinCreERT2;MYO5BF/F mice (n ¼ 9) by one intraperitoneal
injection of tamoxifen (2 mg). Mice were killed 3 days after
the tamoxifen dose. Tamoxifen-injected MYO5BF/F mice and
VillinCreERT2;MYO5BF/þ mice (n ¼ 8) were used as controls
because no difference was found between induced
MYO5BF/F and induced VillinCreERT2;MYO5BF/þ mice. For
Cre recombinase activation in neonatal mice, 2-day-old
VillinCreERT2;MYO5BF/þ (controls, n ¼ 6) and Villin-
CreERT2;MYO5BF/F (n ¼ 4) littermates were given subcu-
taneous injections of tamoxifen (0.5 mg/g/day) for 2
consecutive days and killed 3 days after the ﬁrst tamoxifen
injection.
Immunoﬂuorescence
For MYO5B knockout (KO) and VillinCre;MYO5BF/F mice,
pups were euthanized between 2 and 8 days of age. Excisedintestines were ﬁxed in 4% paraformaldehyde overnight at
4C and embedded in parafﬁn. Sections were deparafﬁnized
and rehydrated before antigen retrieval was performed using
Target Retrieval solution (DakoCytomation, Glostrup,
Denmark) in a pressure cooker for 15 minutes. After cool
down on ice, sections were blocked with the Mouse on Mouse
Basic Kit (Vector Laboratories, Burlingame, CA) for 20 mi-
nutes at room temperature (except for mouse IgG staining),
followed by protein block serum-free (Dako) for either 1 hour
at room temperature or overnight at 4C. The following pri-
mary antibodies were incubated at 4C overnight: chicken
anti-MYO5B (1:200),9,12 rabbit anti-ezrin (1:200, cat. 3145;
Cell Signaling, Danvers, MA), goat anti–dipeptidyl peptidase-4
(DPPIV) (1:200, cat. AF954; R&D Systems, Minneapolis, MN),
mouse anti-CD10 (1:100, cat. ab47721; Abcam), mouse anti-
CD10 (1:60, cat. 10R-CD10aHU; Fitzgerald, Acton, MA) (used
for VillinCreERT2;MYO5BF/F neonate studies), rat anti-Lamp2
(1:200, cat. ab13524; Abcam), rabbit anti-Rab8a (1:200),9,13
rabbit anti-Rab11a (1:200, cat. R0009; US Biological Life Sci-
ences, Salem, MA), rabbit anti-syntaxin 3 (STX3; 1:200, cat.
ab4113; Abcam), rabbit anti–sodium-hydrogen exchanger 3
protein (NHE3) (1:200, a gift from Dr F. Ghishan, University
of Arizona, Phoenix, AZ), rabbit anti–phosphorylated ezrin-
radixin-moesin (pERM) (1:200, cat. 3149; Cell Signaling),
mouse anti–E-cadherin (1:200, cat. 610181; BD Biosciences,
Franklin Lakes, NJ), mouse anti-p120 (1:200, cat. 610133; BD
Biosciences), mouse anti–Na/K–adenosine triphosphatase
(ATPase) (1:50, cat. 05-369; Millipore, Billerica, MA), rabbit
antilysozyme (1:2000, cat. ab108508; Abcam), rabbit anti-
Muc2 (1:200, cat. sc-15334; Santa Cruz, Dallas, TX), rabbit
anti-Chga (1:100, cat. ab17064; Abcam), and rabbit anti-villin
(1:100, cat. R814; Cell Signaling). After 3 washes in 1
phosphate-buffered saline for 5 minutes each, sections were
incubated for 1 hour at room temperature with the appro-
priate secondary antibodies conjugated for immunoﬂuores-
cence with Alexa Fluor 488, Alexa Fluor 647, Cy2, Cy3, Cy5, or
Cy7 (1:500; Molecular Probes, Eugene, OR; or Jackson
ImmunoResearch, West Grove, PA). For Ki67 immunoﬂuo-
rescence, sections were incubated with directly conjugated
anti-Ki67–Alexa Fluor 647 (1:50, cat. 652408; BioLegend) at
the same time as the secondary antibodies. Slides then were
washed 3 times with 1 phosphate-buffered saline and
mounted with ProLong Gold Antifade Reagent with 40,6-
diamidino-2-phenylindole (Invitrogen). For mouse IgG
immunoﬂuorescence, sections were incubated with goat anti-
mouse IgG (HþL) Alexa Fluor 488 (cat. A11029; Molecular
Probes) at the time of primary antibody incubation. This
signal then was ampliﬁed by incubation with donkey anti-goat
Alexa Fluor 488 (cat. A11055; Molecular Probes) at the time
of secondary antibody incubation. All sections were analyzed
using Zeiss Axiophot microscope equipped with an Axiovision
digital imaging system (Zeiss, Jena GmBH, Germany) or an
Olympus FV1000 confocal microscope (Tokyo, Japan).Quantitation of Fused Villi, Inclusions,
Proliferation, and Paneth Cells
For quantitation of fused villi and inclusions, slides
immunostainedwith the appropriate antibodieswere scanned
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Jose, CA). Three randomly selected sections of well-oriented
duodenum and ileum were selected for quantitation. A total
approximate intestinal length of 1.5 mm (for MYO5B KO), 2
mm (for VillinCre;MYO5BF/F), or 2.5–3.5 mm (for Villin-
CreERT2;MYO5BF/F) was quantiﬁed per mouse (n ¼ 3) from
both theduodenumand the ileum for fusedvilli and inclusions.
For fused villi quantitation, a villus structure was considered
fused if the apical membrane of a villus was observed on
exiting the crypt (as marked by ezrin immunostaining), but
later was lost in conjunction with a neighboring villus. For
example, if 2 separate villi with marked apical membranes
emerged from crypts but later converged and lost sections of
apical membrane accompanied by obvious interconnected
cells (as marked on the basolateral membrane by p120
immunostaining), 2 fused villi were counted. For comparisons,
the total number of fused villi then was normalized by the
linear length of intestine quantiﬁed.
The same regions of tissue used for fused villi quanti-
tation were used for quantiﬁcation of inclusions. Inclusions
were identiﬁed as being round internal ezrin-positive
structures (obvious deep invaginations from the apical
membrane not normally found in controls also were
included as inclusions). The total number of inclusions was
quantiﬁed as the total counted number of ezrin-positive
inclusions normalized by the total linear length of tissue
examined. For co-labeled inclusions, these same regions
were examined for ezrin and CD10 or ezrin and DPPIV
co-labeled inclusions. All ezrin-positive inclusions identiﬁed
for the total inclusion quantitation were examined for
co-labeling with either CD10 or DPPIV. The number of dual-
labeled inclusions was presented as the percentage of the
total ezrin-positive inclusions that co-labeled with CD10 or
DPPIV.
For quantitation of proliferation and presence of Paneth
cells, sections immunostained for either Ki67 (proliferation)
or lysozyme (Paneth cells) were analyzed. Two regions of
randomly selected, well-oriented crypts from the duodenum
of each mouse (n ¼ 3 for each group) were examined for the
total number of Ki67-positive cells. At least 5 crypts from
each mouse were quantiﬁed. The total number of Ki67-
positive cells was normalized by the number of crypts
counted to obtain the average number of proliferating cells
per crypt. The early maturation of Paneth cells in neonatal
mice was quantiﬁed by lysozyme immunostaining. Again, 2
regions of randomly selected, well-oriented crypts (for 5–10
crypts total) from the duodenum of each mouse (n ¼ 3)
were quantiﬁed for the number of lysozyme-positive cells.
The total number of lysozyme-positive cells was normalized
by the number of crypts counted. All comparisons were
performed using a 1-tailed Mann–Whitney U test (GraphPad
Prism) with a signiﬁcant P value of .05 or less.Electron Microscopy
For transmission electron microscopy (TEM) and scan-
ning electron microscopy (SEM) preparation, freshly excised
duodenum tissue was washed quickly in 0.1 mol/L cacody-
late buffer. Samples then were ﬁxed in 2.5% glutaraldehyde(in 0.1 mol/L sodium phosphate buffer, pH 7.4, 0.1 mol/L
cacodylate buffer) for 30 minutes at room temperature fol-
lowed by overnight ﬁxation at 4C. After washing, samples
were treated with 1% osmium tetroxide for 1 hour and
dehydrated through serial ethanol dilutions (30%, 50%,
70%, 95%, and 100%). For SEM, after ethanol dehydration,
samples were incubated with hexamethyldisilazane, moun-
ted on stubs, and coated with gold in a sputter coater. Images
were obtained using an FEI Quanta 250 scanning electron
microscope (Hillsboro, OR). For TEM, tissue was incubated
with propylene oxide followed by removal of ethanol from
the samples before inﬁltration with and embedding in EPON
812 resin (Electron Microscopy Sciences, Hatﬁeld, PA). Ul-
trathin sections (70- to 80-nm thick) were cut and collected
on 300-mesh copper grids. Sections were stained with 2%
uranyl acetate and then Reynold’s lead citrate. Images were
obtained using a Philips/FEI T-12 Tecnai T12 electron
microscope (Hillsboro, OR). For quantiﬁcation of microvilli
length and width, TEM images were evaluated for at least 60
microvilli from each mouse using an AMT Image Capture
Engine (Woburn, MA) to analyze images obtained with a DVC
camera (Austin, TX). Statistical differences were determined
using a 1-tailed Mann–Whitney U test (GraphPad Prism) with
a signiﬁcant P value of .05 or less.
Results
MYO5B Germline KO Mice Display Failure
to Thrive, Aberrant Villi Structure, and
Microvillus Inclusions
Breeding of C57BL/6 MYO5B heterozygous mice did not
yield any viable MYO5B KO pups after 1 year of breeding,
thus C57BL/6 MYO5B heterozygous mice were crossed onto
the outbred CD1 background. After 3 generations, viable
C57BL/6;CD1 germline MYO5B KO pups were obtained.
Analysis of MYO5B by PCR and Western blot conﬁrmed the
loss of MYO5B messenger RNA and protein (Figure 2A and
B). Furthermore, immunoﬂuorescence for MYO5B showed
loss of MYO5B from the intestine of MYO5B KO mice
(Figure 2C). Although MYO5B KO mice were indistinguish-
able from both wild-type and heterozygous littermates at
birth, by 3 days old, MYO5B KO mice had a signiﬁcantly
higher percentage of water in their stool (Figure 2D). By 5
days old, MYO5B KO mice were visibly smaller and weighed
signiﬁcantly less than both wild-type and heterozygous lit-
termates (Figure 2E and F). No differences in weight or
pathology were seen between wild-type and heterozygous
MYO5B mice, so both were used as controls in further
studies. Of note, colon and liver histology in MYO5B KO mice
appeared predominately normal, so further studies focused
on the small intestine.
In control duodenum, ezrin immunostained the microvilli
on the apical surface of enterocytes along the villi (Figure 3A).
InMYO5BKOduodenum, ezrin immunostaining showed fused
villi (Figure 3A) with approximately 8 fused villi per 500-mm
length of duodenum (Figure 4C). Previous studies have noted
villus fusion in MVID patients14 as well as in ezrin KO mice.15
In addition, we observed intracellular ezrin-positive in-
clusions (Figure 3A) at a prevalence of 140 inclusions per 500-
Figure 2. Germline MYO5B KO mice fail to thrive. (A) PCR of complementary DNA from wild-type (WT), MYO5B Het, and
MYO5B KO mouse duodenum conﬁrmed Myo5B messenger RNA loss. Tata-box binding protein (TBP) was used as a loading
control. (B) Western blot of duodenum conﬁrms MYO5B protein loss in a MYO5B germline KO mouse as compared with a
MYO5B heterozygote mouse. VDAC was used as a loading control. (C) Immunoﬂuorescence for MYO5B in control duodenum
shows subapical staining. This subapical staining was lost in MYO5B KO duodenum. Scale bar: 50 mm (D) The percentage of
stool constituted by water was calculated in control and MYO5B KO mice (n ¼ 3). MYO5B KO mice had signiﬁcantly higher
water content in stool collected from the colon. *P ¼ .05. (E) Picture of control and MYO5B KO littermates at 5 days old shows
the reduced size of MYO5B KO mice. (F) Mice weighed at 6 days old show no difference between WT and MYO5B Het mice.
MYO5B KO mice were signiﬁcantly smaller than control littermates (both WT and Het) (n¼3). *P ¼ .05.
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clusions typically were circular, with a diameter of 2–4 mm.
The ezrin-positive inclusions appeared along the entire length
of the villi beginning in cells just emerging from the crypts. To
examine the effects of MYO5B loss on other enterocyte com-
ponents previously shown as disrupted in MVID patients,9,16
MYO5B KO duodenum was immunostained for DPPIV and
CD10. In control proximal small intestine, DPPIV predomi-
nately labeled the apical surface with only a small amount of
subapical DPPIV observed, and CD10 localized to the apical
surface of enterocytes. In contrast, in MYO5B KO duodenum, a
signiﬁcant subapical localization of DPPIV was observed as
well as localization in small punctate vesicles and ezrin-positive inclusions (Figure 3B and C). Similarly, CD10 was
decreased markedly along the apical surface and also mis-
localized to a subapical compartment and in ezrin-positive
inclusions in MYO5B KO duodenum (Figure 3B and C). More
than 98% of ezrin-positive inclusions co-labeled with CD10
and DPPIV (Figures 3C and 4E).
The proximal small intestine was compared with the
distal small intestine in MYO5B KO mice to examine dif-
ferences along the length of the small intestine. Ezrin
labeled the apical surfaces along the villi of the control distal
small intestine, outlining individual villi as seen in the
control duodenum. Although MYO5B KO duodenum had
numerous fused villi, ezrin immunostaining of the MYO5B
Figure 3. Immunoﬂuorescence of MYO5B KO duodenum.
(A) Ezrin immunostaining in control mice show a fully formed
brush border along the length of single villi. The inset shows
no internal ezrin staining. In MYO5B KO duodenum, ezrin
labeled internal inclusions in addition to the apical brush
border. Left inset: inclusions formed in cells just exiting the
crypt (arrowhead). Inclusions also were found forming along
the apical membrane (arrowhead, right inset). Ezrin immuno-
staining also showed fused villi in MYO5B KO duodenum.
Scale bar: 100 mm. (B) DPPIV and CD10 both labeled the
apical brush border in control mice with no internal structures
labeled (inset). In MYO5B KO duodenum, DPPIV and CD10
was collapsed from the apical surface into a diffuse subapical
localization (*) as well as localized to internal inclusions
(arrowheads). DPPIV also was found localized to small
punctate vesicles (DPPIV inset). Scale bar: 50 mm. (C) MYO5B
duodenum immunostained for ezrin (green), CD10 (red), and
DPPIV (blue) show ezrin-positive inclusions co-labeled with
CD10 and DPPIV (arrowhead). Scale bar: 50 mm.
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controls (Figure 4A and C). Likewise, signiﬁcantly fewer
Ezrin-positive inclusions were observed in the distal small
intestine than in the proximal intestine of MYO5B KO mice
(Figure 4A and D). No inclusions were noted in the colonic
mucosa of MYO5B KO mice (Figure 4F).
We next used DPPIV immunostaining to examine
expression along the intestinal tract. CD10 expression was
not used for distal small intestine analysis because we noted
CD10 expression signiﬁcantly decreases in normal murine
distal small intestine (data not shown). In control distal
small intestine, DPPIV labeled the apical surface as well as asmall subapical compartment (Figure 4B). DPPIV immuno-
staining of MYO5B KO mouse distal small intestine showed
few intracellular inclusions, similar to the ezrin immuno-
staining (Figure 4B). However, when ezrin-positive in-
clusions were observed in the distal intestine, they usually
also stained for DPPIV (Figure 4E). In addition, in MYO5B
KO intestine, the localization of DPPIV to small punctate
vesicles in the duodenum was not observed in the distal
small intestine (Figure 4B). These ﬁndings indicate that
MYO5B loss induces a gradient of pathology along the length
of the small intestine with the predominate pathology
located in the proximal intestine.
To examine the ultrastructure of the inclusions found
predominately in the duodenum, we performed TEM on
duodenum from 7-day-old MYO5B KO mice. By TEM anal-
ysis, inclusions with microvilli were observed inside enter-
ocytes (Figure 5). In addition, omega-shaped invaginations
containing apical microvilli were observed at the apical
surface. Thus, MYO5B germline KO mice developed micro-
villus inclusions, as seen in MVID patients.
In MYO5B knockdown Caco2-BBE cells, internalized
DPPIV was trafﬁcked to lysosomes.9 To examine if the
internal DPPIV punctate vesicles or the ezrin-positive
microvillus inclusions were localized with lysosomes, we
co-immunostained for DPPIV or ezrin with Lamp2. In con-
trol duodenum, Lamp2-positive lysosomes were located
subapically just under the ezrin- and DPPIV-positive brush
border (Figure 6A and B). In MYO5B KO duodenum, a subset
of ezrin-positive inclusions were not localized near Lamp2-
positive lysosomes, whereas other ezrin-positive inclusions
appeared to be surrounded closely by, but not co-localized
with, Lamp2-positive lysosomes (Figure 6A). Similarly,
internal DPPIV found on microvillus inclusions did not
co-localize with Lamp2 (Figure 6B). However, the DPPIV-
positive punctate vesicles in KO duodenum co-labeled
with Lamp2 suggests that a portion of the internalized
DPPIV not found in ezrin-positive microvillus inclusions was
diverted to lysosomes (Figure 6B).Germline MYO5B Loss Disrupts Apical
Trafﬁcking But Not Microvilli Formation
or Basolateral Protein Localization
To determine the effects of MYO5B loss on apical traf-
ﬁcking and polarity, we examined immunostaining for apical
trafﬁcking proteins (Rab8a, Rab11a, and STX3), the apical
NHE3, and pERM, as a reﬂection of phosphorylated ezrin in
microvilli. Recent studies have shown that loss of MYO5B
results in dispersion of MYO5B binding proteins Rab8a and
Rab11a.9,11 In control duodenum, Rab8a and Rab11a were
concentrated predominately in the subapical compartment
(Figure 7). In MYO5B KO duodenum, Rab8a was decreased
signiﬁcantly from its normal subapical location and instead
was localized to inclusions (Figure 7). In addition, normal
Rab11a localization was lost and only occasional inclusions
were labeled with Rab11a in MYO5B KO duodenum
(Figure 7). Loss of Rab11a from enterocytes has been shown
to alter the localization of the apical soluble NSF attachment
protein receptor protein, STX3.17 STX3 was limited to the
Figure 4. Comparison of distal small intestine and colon. (A) Distal small intestine from control and MYO5B KO mice was
immunolabeled for ezrin. In control distal small intestine, ezrin labeled the apical brush border with no intracellular immuno-
reactivity, as found in the proximal intestine. Distal MYO5B KO small intestine showed only occasional fused villi and few ezrin-
positive inclusions along with the apical membrane labeling. Scale bar: 100 mm. (B) In control distal small intestine, DPPIV
labeled the apical membrane with a small subapical population. DPPIV localization in MYO5B KO distal small intestine
appeared similar to control tissue with a compact subapical localization in addition to the apical membrane. In addition, fewer
DPPIV-positive intracellular inclusions were found. Scale bar: 50 mm. (C) The number of fused villi was counted in both the
proximal and distal intestine in control and MYO5B KO mice. MYO5B KO proximal intestine had approximately 8 fused villi per
500-mm length of intestine, which was increased signiﬁcantly from the controls. A decreasing gradient in the number of fused
villi was observed in MYO5B KO intestine with only rare fused villi found in the distal small intestine. *P ¼ .05. (D) MYO5B KO
duodenum had approximately 140 ezrin-positive inclusions per 500 mm of intestine. Again, the number of inclusions was
decreased signiﬁcantly in MYO5B KO distal small intestine as compared with MYO5B KO duodenum. *P ¼ .05. (E) The
percentage of ezrin-positive inclusions that co-labeled with CD10 or DPPIV was quantiﬁed. More than 98% of all ezrin-positive
inclusions were dual-labeled with ezrin and CD10 or ezrin and DPPIV. No difference in co-labeled inclusions was found
between the proximal and distal small intestine. (F) Colon from control and MYO5B KO mice was immunolabeled for ezrin. No
microvillus inclusions were observed in MYO5B KO colon. Scale bar: 50 mm.
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Figure 5. TEM identiﬁcation of microvillus inclusions. TEM analysis of MYO5B KO duodenum showed inclusions with fully
formed microvilli, conﬁrming the formation of microvillus inclusions. Several microvillus inclusions were visualized within the
enterocytes of the duodenum (left four panels). Scale bar: 4 mm. In addition, microvillus inclusion was visualized at the apical
membrane with characteristic omega-shaped invaginations of the brush-border microvilli (right panel). Scale bar: 2 mm.
Figure 6. Trafﬁcking of ezrin-positive inclusions and
DPPIV. (A) Duodenum from control and MYO5B KO mice
were co-stained for ezrin (green) and Lamp2 (red). In control
enterocytes, Lamp2-positive lysosomes concentrated just
under the apical surface. Upon MYO5B loss, a subset of
ezrin-positive inclusions were surrounded closely or cupped
by Lamp2-positive lysosomes (arrowheads). However, other
ezrin-positive inclusions were not located near Lamp2
(arrows). Scale bars: 25 mm. (B) In controls, the small DPPIV
population occasionally found in the subapical region
co-localized with Lamp2. *In MYO5B KO duodenum, the
subset of DPPIV that mistrafﬁcked to small punctate vesicles
was found to co-label with Lamp2. Scale bars: 25 mm.
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MYO5B KO duodenum, STX3 was more dispersed into the
cytoplasm as well as localized to some microvillus in-
clusions (Figure 7). Similar to the disruption of the apical
trafﬁcking proteins, the apical NHE3 also was mislocalized.
Although NHE3 was found strictly on the apical membrane
in normal duodenum, in MYO5B KO mice, NHE3 was
collapsed into a diffuse subapical localization as well as
localized in inclusions (Figure 7). To examine the effects of
MYO5B loss on a structural component of the apical
microvilli, we immunostained MYO5B KO intestine for
pERM. Although the apical pERM localization was retained
in MYO5B KO intestine, pERM also clearly labeled inclusions
(Figure 7), further validating the presence of mature
microvilli within the inclusions and suggesting the retention
of apical microvilli on enterocytes along the villi.
To study the effects of MYO5B loss on basolateral
trafﬁcking, we immunostained for E-cadherin, p120, and Na/
K-ATPase. All 3 proteins were found on the basolateral
membrane in control duodenum. This basolateral localization
was maintained in MYO5B KO duodenum (Figure 8). In
addition, immunostaining of these 3 basolateral proteins
highlighted the fusion of villi and the potential disorganization
of enterocytes in these fused villi. This disorganization caused
by villi fusionmay confound the observation of subtle changes
in basolateral trafﬁcking. No changes were found for immu-
nostaining of tight junction proteins (data not shown).
Although germline deletion of MYO5B led to a
disruption and mislocalization of a number of apical
trafﬁcking proteins, ezrin and pERM staining suggest the
presence of structurally intact apical microvilli in MYO5B
KO mice. Thus, we performed TEM and SEM to assess the
presence of apical microvilli in the enterocytes. TEM of
control duodenum showed long, straight microvilli along
the apical surface (Figure 9A). Apical microvilli were
retained in MYO5B KO duodenum (Figure 9B). However,
similar to the previously reported Rab11a KO mouse,17,18
MYO5B KO duodenum showed signiﬁcantly shortened and
wider apical microvilli (Figure 9B and C). Although
microvilli were shorter in comparison with control duo-
denum (Figure 9D), normal packing of microvilli was
found in MYO5B KO duodenum (Figure 9E), suggesting
Figure 7. Disruption of apical trafﬁcking in MYO5B KO duodenum. Control (top row) and MYO5B KO (bottom row)
duodenal sections were immunostained for apical proteins (Rab8a, Rab11a, STX3, NHE3, and pERM). Apical trafﬁcking
proteins, Rab8a, Rab11a, and STX3, were concentrated subapically in control tissue, with Rab8a also labeling along lateral
membranes. *Rab8a and Rab11a were lost from the apical membrane and occasionally localized to inclusions (arrowheads) in
MYO5B KO duodenum. STX3 was collapsed into a broad and diffuse subapical region (asterisks and arrowheads), as well as
localized to inclusions (arrowheads). The apical exchanger NHE3 was normally located on the apical membrane of enterocytes
in the small intestine. Upon MYO5B loss, NHE3 was mislocalized to a diffuse subapical compartment (asterisks) and labels
inclusions (arrowheads). In addition, a microvilli structural protein, pERM, was examined to further investigate the status of
microvilli in MYO5B KO tissue. pERM in control duodenum labeled only on the apical surface of the villus enterocytes. As with
ezrin, in MYO5B KO duodenum, pERM immunostaining identiﬁed microvillus inclusions inside enterocytes as well as the
formation of microvillus inclusions at the apical surface of enterocytes (arrowheads). Scale bars: 50 mm.
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upon loss of MYO5B in neonates.Disruption of Apical Trafﬁcking, But Not
Microvillus Inclusion Formation, Is Present
in Embryonic MYO5B KO Duodenum
We examined embryonic (embryonic day E18.5) duo-
denum from control and MYO5B KO littermates to deter-
mine the onset of the apical trafﬁcking disruption and the
formation of microvillus inclusions. Embryonic duodenum
was immunostained for ezrin, DPPIV, CD10, and NHE3.
Embryonic control duodenum showed strict apical locali-
zation of each marker (Figure 10), similar to that seen in
neonatal control duodenum. Although neonatal MYO5B KO
duodenum showed numerous ezrin-positive inclusions
(beginning at 1 day old), E18.5 MYO5B KO duodenum did
not possess ezrin-positive inclusions (Figure 10). However,
mislocalization of the apical markers DPPIV, CD10, and
NHE3 into a subapical compartment was observed in the
embryonic KO duodenum (Figure 10).
Because previous studies have suggested that the duo-
denum is primed for maternal IgG uptake in neonatalrodents,19–21 we dual immunostained for murine IgG and
ezrin to assess the presence of maternal IgG inside the
inclusions found in MYO5B KO neonates. Neonatal MYO5B
KO duodenum sections were immunostained with an Alexa
488–conjugated goat anti-mouse IgG antibody to label native
mouse IgG from maternal milk. No signiﬁcant internal re-
gions of concentrated IgG were found in control neonatal
duodenum (Figure 11). In MYO5B KO duodenum, although
not all inclusions immunostained for IgG, a prominent subset
of ezrin-positive inclusions did co-label with murine IgG
(Figure 11). These ﬁndings support the origin of microvillus
inclusions through internalization of apical membrane.Germline MYO5B Loss Leads to Crypt
Hyperproliferation and Early Maturation
of Paneth Cells
BecauseMYO5B loss results in aberrant villi structure, we
examined the effects of MYO5B loss on proliferation and the
cell lineages in the duodenum. Ki67 immunostaining showed
a signiﬁcant increase in proliferating cells within MYO5B KO
crypts as compared with control crypts (12 vs 9 cells per
crypt, respectively) (Figure 12A and C). No proliferating cells
Figure 8. Immunoﬂuo-
rescence staining for
basolateral trafﬁcking.
Duodenum sections were
immunostained for junc-
tional proteins E-cadherin
and p120 and the baso-
lateral Na/K-ATPase. All 3
proteins were localized to
the basolateral membrane
in control duodenum (top
row). Similar basolateral
localization was observed
in MYO5B KO duodenum
(bottom row), thus showing
no disruption in basolateral
trafﬁcking upon MYO5B
loss. Scale bars: 50 mm.
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Lysozyme immunostaining was used to assess the presence
of Paneth cells in the neonatal mice. Paneth cells do not
normally mature in neonatal mice until 14 days of age.22
Accordingly, in control duodenum, only rare lysozyme-
positive Paneth cells were observed (Figure 12B and C). In
MYO5B KO duodenum, early maturation of Paneth cells
within the crypts was seen (Figure 12B and C). In contrast to
the crypt, no signiﬁcant differences were observed in the
differentiation of secretory cell lineages along the villi,
including enteroendocrine cells (labeled by chromogranin A)
and goblet cells (labeled by Muc2) (Figure 12D).
Intestine-Targeted MYO5B Deletion in Mice
Recapitulates the Pathology in Germline MYO5B
KO Mice
To examine the role of MYO5B speciﬁcally in the intes-
tine, we generated intestine-targeted MYO5B deletion miceby crossing VillinCre mice to MYO5BF/F to produce Villin-
Cre;MYO5BF/F mice. In contrast to the germline MYO5B KO
mice, viable VillinCre;MYO5BF/F pups were obtained on a
C57BL/6 background. MYO5B immunostaining in intestinal
sections conﬁrmed loss of MYO5B along the length of the
small intestine (Figure 13A) and colon (data not shown).
Nevertheless, VillinCre;MYO5BF/F failed to thrive and did
not survive past 6 days of age. Although indistinguishable
from control littermates at birth, by 5 days of age, Villin-
Cre;MYO5BF/F mice showed evidence of dehydration and
were visibly smaller (Figure 13B and C). No differences in
weight or pathology were observed between MYO5BF/F and
VillinCre;MYO5BF/þ mice, and thus both were used as con-
trols in further studies.
Ezrin immunostaining in VillinCre;MYO5BF/F duo-
denum showed fused villi at a rate of 5.4 fused villi
per 500-mm length of intestine (Figure 13D and E). In
addition, ezrin-positive inclusions were found within the
Figure 9. TEM and SEM
analysis of apical micro-
villi. (A) Control duodenum
was imaged by TEM. Im-
ages show long and
straight microvilli on the
apical surface of enter-
ocytes. Scale bar: 2 mm. (B)
TEM imaging of MYO5B
KO duodenum showed
shortened apical microvilli.
Scale bar: 2 mm. (C) The
length and width of apical
microvilli from control and
MYO5B KO duodenum
was measured. In MYO5B
KO duodenum, microvilli
were half the height of
control microvilli. In addi-
tion, microvilli were slightly
wider in MYO5B KO
duodenal enterocytes. *P
< .05. (D) Control duo-
denum examined by SEM
showed tightly packed
microvilli. Scale bar: 5 mm.
(E) By SEM, tightly packed
microvilli were visualized in
MYO5B KO duodenum,
showing that packing
remained largely un-
changed even with short-
ened microvilli. Scale bar:
5 mm.
March 2016 Mouse Models of MYO5B Knockout 141enterocytes along the villi in the proximal small intestine
(averaging 82 ezrin-positive inclusions per 500-mm length
of intestine) (Figure 13D and E). We then examined the
number of fused villi and ezrin-positive inclusions in the
distal small intestine of VillinCre;MYO5BF/F mice. Similar
to MYO5B KO mice, a decreasing gradient was observed
between the proximal and distal small intestine. Only rare
fused villi were observed in the VillinCre;MYO5BF/F mouse
distal small intestine and the presence of ezrin-positive
inclusions was signiﬁcantly less frequent (<5 ezrin-
positive inclusions per 500-mm length of intestine)
(Figure 13D and E). However, regardless of the location of
the ezrin-positive inclusions (proximal vs distal), morethan 97% of all ezrin-positive inclusions co-labeled with
CD10 and DPPIV (Figure 13E).VillinCre;MYO5BF/F Mice Show Disruption of
Apical Trafﬁcking, But Not Basolateral Protein
Localization or Microvilli Formation
Although normal localization of pERM to the apical brush
border was retained in VillinCre;MYO5BF/F mouse duo-
denum, pERM-positive inclusions also were observed in the
cytoplasm of enterocytes along the villi (Figure 14A). Similar
to the apical trafﬁcking disruption found in germline MYO5B
KO mice, strict apical localization of NHE3, CD10, and DPPIV
Figure 10. Immunoﬂuorescence staining of embryonic duodenum. Embryonic (E18.5) duodenum from control and MYO5B
KO littermates was immunostained for apical markers to examine mistrafﬁcking and microvillus inclusion formation. As in
neonates, all markers (ezrin, DPPIV, CD10, and NHE3) labeled the apical membrane in control embryonic duodenum (top row).
In contrast to neonates, ezrin-positive inclusions were not observed in MYO5B KO duodenum, suggesting that microvillus
inclusions were not formed until after birth. However, DPPIV, CD10, and NHE3 staining was collapsed to a subapical local-
ization (asterisk) not found in the control littermates. These ﬁndings show apical mistrafﬁcking is present before birth, but
microvillus inclusions likely do not form until after birth. Scale bars: 50 mm.
Figure 11. IgG internali-
zation in ezrin-positive
inclusions. Mouse IgG
internalization was visual-
ized by immunoﬂuores-
cence staining for mouse
IgG (Ms IgG, green) and
ezrin (red). To detect
endogenous mouse IgG,
the Mouse on Mouse block
kit could not be used, thus
resulting in high back-
ground signal from inter-
stitial cells. Nonetheless,
no signiﬁcant internal
mouse IgG was observed
in control duodenum (left
panels). In contrast, in
MYO5B KO duodenum,
mouse IgG was found in-
side ezrin-positive in-
clusions (right panels).
Scale bars: 10 mm.
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Figure 12. Proliferation and cell lineages in MYO5B KO duodenum. (A) Ki67 was used as a marker of proliferation.
Sections were stained for Ki67 (red) and p120 (green). Ki67-positive proliferating cells were conﬁned to the short crypts in
control mice. In MYO5B KO mice, an increase in proliferation was observed as well as an expansion of the crypt.
4’,6-diamidino-2-phenylindole (blue). Scale bar: 50 mm. (B) To determine the status of Paneth cells, sections were immu-
nostained for Lysozyme (red) and E cadherin (E-cad) (green). A premature maturation of Paneth cells was observed in
MYO5B KO duodenum. Scale bar: 50 mm. (C) The number of Ki67-positive proliferating cells per crypt was quantiﬁed for
both control and MYO5B KO duodenum. A small but signiﬁcant increase in proliferation was found in MYO5B KO duo-
denum. *P ¼ .05. (B) Lysozyme-positive Paneth cells appear earlier in MYO5B KO than in control littermates. Although less
than 1 Paneth cell per 10 crypts was found in control duodenum, more than 4 Paneth cells per 10 crypts were counted in
MYO5B KO duodenum *P ¼ .05. (D) Tissue sections were co-stained for lineage markers Muc2 or Chga (red) and p120
(green). Goblet cells (Muc2-positive) and enteroendocrine cells (Chga-positive) were present in both control and MYO5B
KO tissue. Scale bar: 50 mm.
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Figure 13. Characterization of VillinCre;MYO5BF/F intestine. (A) Proximal and distal small intestine from control and
VillinCre;MYO5BF/F mice was immunostained for MYO5B (green) and Na/K-ATPase (red). A clear subapical concentration of
MYO5B was observed in control tissue, however, this immunoreactivity was lost in VillinCre;MYO5BF/F intestine (proximal and
distal). Of note, no signiﬁcant changes were observed in Na/K-ATPase expression and localization. Scale bar: 25 mm. (B) An
image of a VillinCre;MYO5BF/F mouse and a control littermate mouse show an obvious size difference. (C) Mice weighed at 5
days old showed that VillinCre;MYO5BF/F mice were approximately half the weight of control littermates. *P ¼ .05 (D) Ezrin
immunoﬂuorescence showed fused villi (green arrow) and the presence of ezrin-positive inclusions in VillinCre;MYO5BF/F
proximal small intestine. However, only occasional inclusions were observed in the VillinCre;MYO5BF/F distal small intestine
and, rarely, fused villi (lower right panel). Scale bar: 50 mm. (E) Similar to germline MYO5B KO mice, VillinCre;MYO5BF/F mice
showed a gradient of phenotype from proximal to distal small intestine. Approximately 5 fused villi per 500-mm length of
proximal intestine was measured, which decreased to only rare fused villi in the distal small intestine. Likewise, the Villin-
Cre;MYO5BF/F small intestine showed signiﬁcantly fewer inclusions in the distal small intestine compared with proximal. Again,
more than 98% of all ezrin-positive inclusions also labeled with CD10 or DPPIV with no signiﬁcant differences found between
the proximal and distal small intestine. *P ¼ .05. SI, small intestine.
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March 2016 Mouse Models of MYO5B Knockout 145was lost in VillinCre;MYO5BF/F mouse enterocytes
(Figure 14A). Localization of these proteins expanded into a
more diffuse subapical region as well as localizing to the
internal inclusions found in VillinCre;MYO5BF/F mouse
duodenum. DPPIV also was dispersed into punctate vesicles
within the enterocyte cytoplasm (Figure 14A). Examination
of DPPIV localization in VillinCre;MYO5BF/F mouse distal
small bowel showed near absence of the internal DPPIV-
positive punctate vesicles found in the proximal small
intestine of VillinCre;MYO5BF/F mice (Figure 14A). Although
a more diffuse subapical DPPIV localization was noted in the
distal small intestine of VillinCre;MYO5BF/F mice than in
controls, the clear presence of apical brush-border DPPIV
localization, in addition to the lack of DPPIV-positive in-
clusions and punctate vesicles, further shows the presence
of a gradient of pathologic changes upon loss of MYO5B
along the small intestine.
To examine the effect of MYO5B loss on apical trafﬁcking
and polarity, VillinCre;MYO5BF/F mouse duodenum was
immunostained for the apical trafﬁcking proteins Rab8a,
Rab11a, and STX3. In control duodenum, Rab8a, Rab11a,
and STX3 were concentrated to the subapical region in
enterocytes, while Rab8a also was distributed along the
lateral membrane (Figure 14B). In VillinCre;MYO5BF/F
mouse duodenum, Rab8a and Rab11a occasionally localized
to inclusions, but overall were dispersed predominately
throughout the cytoplasm or lost in enterocytes
(Figure 14B). Immunostaining for STX3 showed relocation
into a more diffuse subapical distribution, as well as local-
ization in the inclusions (Figure 14B).
The effects of MYO5B loss on basolateral trafﬁcking were
examined by immunostaining for Na/K-ATPase, E-cadherin,
and p120. Loss of MYO5B from VillinCre;MYO5BF/F intestine
did not signiﬁcantly affect Na/K-ATPase localization to the
basolateral membrane (Figure 13A). Similarly, normal
localization of E-cadherin and p120 to the lateral mem-
branes was observed in VillinCre;MYO5BF/F mouse duo-
denum (Figure 14C). Although, as previously noted,
disruption of villi structure and resulting disorganization of
enterocytes may obscure subtle changes in localization of
these basolateral proteins, no signiﬁcant changes were
found in the localization of basolateral proteins.
We next examined if internal ezrin-positive inclusions or
the internalized DPPIV were co-localized with Lamp2-
positive lysosomes. Although some ezrin-positive in-
clusions did not localize near Lamp2 expression, other
ezrin-positive inclusions were surrounded or cupped by
Lamp2-positive lysosomes, but did not directly co-localize
with Lamp2 (Figure 15A). The 2 populations of internal-
ized DPPIV not associated with ezrin-positive inclusions
(both diffuse subapical DPPIV and DPPIV in small punctate
vesicles) both co-labeled with Lamp2 (Figure 15A). These
data show that at least a portion of the internalized apical
proteins likely are diverted to lysosomes.
The ultrastructure of VillinCre;MYO5BF/F mouse
duodenal enterocytes was analyzed by SEM and TEM.
Although VillinCre;MYO5BF/F mouse enterocytes main-
tained apical microvilli, these apical microvilli were signiﬁ-
cantly shorter and wider than microvilli found in controlenterocytes (Figure 16A–C). In addition, inclusions with
mature microvilli frequently were observed in VillinCre;
MYO5BF/F enterocytes by TEM (Figure 16B). Although api-
cal microvilli in VillinCre;MYO5BF/F enterocytes were
signiﬁcantly shorter, SEM showed that this shortened length
did not signiﬁcantly affect packing or organization
(Figure 16D and E).VillinCre;MYO5BF/F Mice Do Not Display
Changes in Proliferation or Cell Lineage
Differentiation
Proliferation in VillinCre;MYO5BF/F duodenal sections
was examined by immunostaining for Ki67. As in control
duodenum, proliferating cells were conﬁned within crypts
(Figure 15B). No signiﬁcant difference was found in the
number of proliferating crypt cells between control and
VillinCre;MYO5BF/F intestines (Figure 15B). In contrast to
germline MYO5B KO intestine, only rare lysozyme-positive
Paneth cells were observed in VillinCre;MYO5BF/F duo-
denum (Figure 15C). Similarly, no signiﬁcant differences in
the presence of goblet cells or enteroendocrine cells in
VillinCre;MYO5BF/F duodenum were observed (Figure 15C).Prominent Mistrafﬁcking and Apical Microvilli
Loss, But Not Microvillus Inclusions, Are the
Predominate Pathologies of Inducible Intestinal
Targeted MYO5B Deletion in Adult Mice
Inducible VillinCreERT2;MYO5BF/F C57BL/6 mice were
obtained by crossing MYO5BF/F mice to VillinCreERT2 mice.
Induction of MYO5B loss in VillinCreERT2;MYO5BF/F mice
was achieved by administration of one intraperitoneal in-
jection of 2 mg of tamoxifen to 8- to 10-week-old mice. Mice
showed signs of distress and were killed 3 days after the
tamoxifen injection. Tamoxifen-injected MYO5BF/F mice
were used as controls. MYO5B loss in both proximal and
distal small intestine was conﬁrmed by MYO5B immuno-
staining (Figure 17A). Although no weight differences were
observed between VillinCreERT2;MYO5BF/F and control mice,
VillinCreERT2;MYO5BF/F mice did develop diarrhea as
conﬁrmed by a signiﬁcantly higher percentage of water
present in the stool (Figure 17B). Based on our ﬁndings
from the neonatal loss of MYO5B, we ﬁrst examined
VillinCreERT2;MYO5BF/F mouse small intestines by ezrin
immunostaining. In the tamoxifen-induced Villin-
CreERT2;MYO5BF/F mouse duodenum, ezrin also was found
on the apical microvilli, although it appeared as a fainter
thinner band along the apical surface or even was
completely lost in some cells (Figure 17C). Notably, only
occasional ezrin-positive inclusions were seen. Indeed, less
than one ezrin-positive inclusion was found per 500-mm
length of duodenum (and only rarely in the distal small
intestine) (Figure 17D). In addition, no evidence for fused
villi was found in either proximal or distal Villin-
CreERT2;MYO5BF/F small intestine (Figure 17D).
Because ezrin immunostaining suggested a shortened or
even lost brush border with only a few intracellular in-
clusions in VillinCreERT2;MYO5BF/F mouse duodenum, we
Figure 14. Disruption of apical trafﬁcking in VillinCre;MYO5BF/F duodenum. (A) Control (top row) and VillinCre;MYO5BF/F
(bottom row) duodenal sections were immunostained for apical proteins (pERM, NHE3, CD10, and DPPIV). pERM staining in
control duodenum showed microvilli located only on the apical surface of the villi enterocytes. In VillinCre;MYO5BF/F
duodenum, pERM immunostaining identiﬁed microvillus inclusions inside enterocytes as well as the formation of microvillus
inclusions at the apical surface of enterocytes (arrowhead). The apical exchanger NHE3 normally was located on the apical
membrane of enterocytes in the small intestine. Upon MYO5B loss, NHE3 was mislocalized to a diffuse subapical
compartment (asterisk) and labeled in inclusions (arrowhead). CD10 and DPPIV both labeled the apical brush border in
control mice. In VillinCre;MYO5BF/F duodenum, CD10 and DPPIV were relocated into a diffuse subapical localization (asterisk)
as well as into internal inclusions (arrowheads). DPPIV also was found localized to small punctate vesicles (arrows). In Vil-
linCre;MYO5BF/F distal small intestine (last column), although some DPPIV subapical accumulation was observed, no apparent
overall difference was noted in comparison with control. Scale bar: 50 mm. (B) Apical trafﬁcking proteins, Rab8a, Rab11a, and
STX3, were concentrated subapically in control tissue, with Rab8a also labeling along lateral membranes. Rab8a and Rab11a
were lost from the apical membrane with a small accumulation in the subapical regions (asterisk), and occasionally localized to
inclusions (arrowheads) in VillinCre;MYO5BF/F duodenum. STX3 was collapsed into a diffuse subapical region (asterisk) as well
as localized to inclusions (arrowheads). Scale bar: 50 mm. (C) Control and VillinCre;MYO5BF/F duodenum were immunostained
for E-cadherin and p120. In both controls and VillinCre;MYO5BF/F duodenum, E-cadherin and p120 labeled the basolateral
membranes with no obvious differences between them. Scale bar: 50 mm. SI, small intestine.
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structural protein, villin. In control duodenum, villin lined
the wide brush border along the apical surface of enter-
ocytes (Figure 17C). Although villin still was localized to theapical surface in VillinCreERT2;MYO5BF/F duodenum, it
labeled a thinner band along the enterocyte apical surface
and was even absent in some regions (Figure 17C). Again,
only occasional villin-positive inclusions were found within
Figure 15. Localization of lysosomes and characterization of cellular make-up in villi. (A) Duodenum from control and
VillinCre;MYO5BF/F duodenum was triple-stained for ezrin (blue), Lamp2 (green), and DPPIV (red). In control enterocytes,
Lamp2-positive lysosomes concentrated just under the ezrin and DPPIV-positive apical surface. In VillinCre;MYO5BF/F duo-
denum, a subset of ezrin-positive inclusions were surrounded closely or cupped by Lamp2-positive lysosomes (arrow).
However, other ezrin-positive inclusions were not located near Lamp2 (arrowhead). DPPIV internalized into small vesicles co-
localized with Lamp2 (asterisks). Scale bar: 25 mm. (B) Control and VillinCre;MYO5BF/F duodenum was analyzed for prolifer-
ating cells (Ki67 in green) and the early maturation of Paneth cells (lysozyme in red). No signiﬁcant differences were found
between the 2 mouse strains. 40,6-diamidino-2-phenylindole (blue). Scale bar: 50 mm. (C) Sections were immunostained for
Muc2 (red, left panel) and Chga (red, right panel) with p120 (green). Similar to the germline MYO5B KO, no signiﬁcant difference
was observed between the control littermates and VillinCre;MYO5BF/F duodenums. 40,6-diamidino-2-phenylindole (blue).
Scale bar: 50 mm.
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border was disrupted upon MYO5B loss in adult mice, but
microvillus inclusion formation (as observed by ezrin or
villin immunoreactivity) could not account for the diarrhea
and dehydration observed in VillinCreERT2;MYO5BF/F mice.To examine the localization of nonstructural apical
components, duodenum sections from tamoxifen-induced
adult VillinCreERT2;MYO5BF/F mice were immuno-
stained for CD10 and DPPIV. Loss of MYO5B in Villin-
CreERT2;MYO5BF/F mouse duodenum resulted in the
Figure 16. TEM and SEM
analysis of apical micro-
villi in VillinCre;MYO5BF/F
mice. (A) Control duo-
denum was imaged by
TEM. Images showed long
and straight microvilli on
the apical surface of
enterocytes. Scale bar: 500
nm. (B) TEM imaging of
VillinCre;MYO5BF/F duo-
denum showed shortened
apical microvilli and the
presence of internal in-
clusions with obvious
microvilli. Scale bar: 500
nm (left panel). TEM anal-
ysis also showed internal
microvillus inclusions with
fully formed microvilli.
Scale bar: 2 mm (right
panel). (C) The length and
width of apical microvilli
from control and Villin-
Cre;MYO5BF/F duodenum
was measured. In Villin-
Cre;MYO5BF/F duodenum,
microvilli were signiﬁcantly
shorter than control micro-
villi. In addition, microvilli
also were wider in Villin-
Cre;MYO5BF/F duodenal
enterocytes. *P < .05. (D)
Control duodenum exam-
ined by SEM showed
tightly packed microvilli.
Scale bar: 2 mm. (E) By
SEM, tightly packed
microvilli were visualized in
VillinCre;MYO5BF/F duo-
denum, showing that
packing remained largely
unchanged even with
shortened microvilli. Scale
bar: 2 mm.
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collapsed into a broad and diffuse subapical localization as
well as diverted to vesicular structures (Figure 18A). DPPIV
also was mislocalized to a subapical region, in addition to
localization in punctate vesicles inside enterocytes
(Figure 18B). As in neonates, Lamp2-positive lysosomes
were concentrated to a narrow subapical region just under
the CD10- and DPPIV-labeled brush border in control adult
duodenum. However, in VillinCreERT2;MYO5BF/F mouse
duodenum, a subset of internalized CD10 co-localized with
Lamp2 (Figure 18A). Similarly, a portion of internalized
DPPIV also co-localized with Lamp2 (Figure 18B). Thus,
upon MYO5B loss, in the duodenum internalized apicalproteins, CD10 and DPPIV, were relocalized to Lamp2-
positive lysosomes. Nevertheless, little internalized DPPIV
was observed in the enterocytes of the distal small intestine
(Figure 18B).
Because apical proteins were mislocalized in tamoxifen-
induced VillinCreERT2;MYO5BF/F mouse duodenum, disrup-
tion of apical trafﬁcking and polarity was investigated. In
VillinCreERT2;MYO5BF/F mouse duodenum, NHE3 was
mislocalized to a diffuse and broad subapical compartment
(Figure 19A). To further investigate apical trafﬁcking, Rab8a
and Rab11a expression and distribution were assessed. The
predominant subapical concentration of Rab8a was lost
in VillinCreERT2;MYO5BF/F enterocytes. Instead, Rab8a was
Figure 17. Characterization of VillinCreERT2;MYO5BF/F mouse small intestine in 8-week-old mice induced with
tamoxifen. Eight-week-old VillinCreERT2;MYO5BF/F mice were treated with a single 2 mg intraperitoneal dose of tamoxifen to
induce intestine KO of MYO5B. (A) Proximal and distal small intestine from control and VillinCreERT2;MYO5BF/F mice were
immunostained for MYO5B. A clear subapical concentration of MYO5B was observed in control tissue, however, MYO5B
immunoﬂuorescence was lost in VillinCreERT2;MYO5BF/F mice in both proximal and distal intestine. Scale bar: 50 mm. (B) The
percentage of stool constituted by water was determined in control and VillinCreERT2;MYO5BF/F mice. VillinCreERT2;MYO5BF/F
mice had signiﬁcantly higher water content in stool collected from the colon (90% stool water). *P ¼ .05. (C) Ezrin immuno-
staining in control mice showed a fully formed brush border along the length of the villi. Inset: a strong sharp band of ezrin-
positive brush border. In VillinCreERT2;MYO5BF/F duodenum, ezrin labeled a thin band along the brush border, suggesting a
shortening or loss of apical microvilli (asterisk). Of note, only occasional ezrin-positive inclusions were observed in Villin-
CreERT2;MYO5BF/F mouse intestines. Similarly, villin labeled a bright and wide brush border in control duodenums. In Villin-
CreERT2;MYO5BF/F duodenums, the apical villin stain was much thinner and even absent in some locations (asterisk), with only
rare inclusions observed. Scale bar: 50 mm. (D) Fused villi and the total number of ezrin-positive inclusions were quantiﬁed. No
difference was observed in the number of fused villi in control and VillinCreERT2;MYO5BF/F proximal and distal small intestine.
There was a signiﬁcant increase in the number of ezrin-positive inclusions as compared with control in the proximal intestine.
However, the total number of inclusions was only 0.75 ezrin-positive inclusions per 500 mm of tissue in VillinCreERT2;MYO5BF/F
duodenums. *P ¼ .05. SI, small intestine.
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although some Rab8a still was found subapically and along
the lateral membrane (Figure 19A). Similarly, Rab11a also
was redistributed from the subapical region to diffuse
cytoplasmic vesicles (Figure 19A).
Although our studies here have shown that MYO5B loss
in neonates did not cause signiﬁcant changes in basolateral
protein localization, previous studies have reported
disruption of basolateral trafﬁcking upon MYO5B
loss.2,3,8,9,11 Again, Na/K-ATPase, E-cadherin, and p120 im-
munostaining was assessed as an indicator of disruption of
basolateral trafﬁcking. In VillinCreERT2;MYO5BF/F mouse
enterocytes, Na/K-ATPase still was localized to the baso-
lateral membrane, however, it also was observed incytoplasmic vesicles in some cells (Figure 19B). Similarly, E-
cadherin also was mislocalized to cytoplasmic vesicles in
addition to the normal basolateral localization (Figure 19B).
The most prominent effect of MYO5B loss on basolateral
proteins was the mislocalization of p120. Loss of MYO5B in
adult duodenum resulted in p120 mislocalization to cyto-
plasmic vesicles similar to that found with Na/K-ATPase
and E-cadherin (Figure 19B). In addition, p120 also was
dispersed into a diffuse cytoplasmic distribution in some
enterocytes (Figure 19B). These ﬁndings suggest that
MYO5B loss in adult duodenum can disrupt basolateral
trafﬁcking dynamics.
Based on our evidence of diminished ezrin and villin
immunostaining of the brush border in adult Villin-
CreERT2;MYO5BF/F mouse enterocytes, we performed TEM
and SEM analysis to assess the status of apical microvilli. By
TEM analysis, we observed a heterogeneous pattern for
microvilli upon MYO5B loss in adult duodenal enterocytes.
Some areas of enterocytes had shorter and wider microvilli
in tamoxifen-induced VillinCreERT2;MYO5BF/F enterocytes
(Figure 20A–C), similar to the pattern found in the neonatal
MYO5B loss models. In contrast to the neonates, some re-
gions of enterocytes showed only few and sparse microvilli
or even complete loss of microvilli (Figure 20B). In areas of
short microvilli, the microvilli remained normally packed as
assessed by SEM (Figure 20E). Cross-sections of other re-
gions showed malformed microvilli that appeared to be
pinched into segments (Figure 20E). This analysis of ultra-
structure conﬁrmed that MYO5B loss in adult enterocytes
resulted in aberrant microvilli structure or even microvilli
loss in some enterocytes. This disturbance of the brush
border, in addition to the apical and basolateral mis-
trafﬁcking, may contribute to the resulting diarrhea
seen after induction of MYO5B loss in adult Villin-
CreERT2;MYO5BF/F mice.Figure 18. Internalization and trafﬁcking of CD10 and
DPPIV to lysosomes. (A) Duodenum from control and Vil-
linCreERT2;MYO5BF/F mice were co-stained for CD10 (green)
and Lamp2 (red). In control enterocytes, Lamp2-positive ly-
sosomes were located just under the CD10-labeled apical
surface. Upon induced MYO5B loss, a subset of CD10 was
internalized (asterisks and arrow). Lamp2 was found sur-
rounding CD10 as it was internalized from the apical surface
(arrow), and, in addition, Lamp2 co-localized with internal
CD10 populations (asterisks). Scale bar: 25 mm. (B) Proximal
and distal small intestine from controls and Villin-
CreERT2;MYO5BF/F mice were immunolabeled for DPPIV
(green) and Lamp2 (red). In both proximal and distal small
intestine controls, DPPIV predominately resided at the brush
border, but a small DPPIV population was found in the sub-
apical region co-localized with Lamp2 (asterisks). In Villin-
CreERT2;MYO5BF/F duodenum, DPPIV was collapsed into a
diffuse subapical region as well as to small punctate vesicles
(asterisks). The DPPIV-labeled vesicles, along with a portion
of the diffuse DPPIV staining, co-labeled with Lamp2 (aster-
isks). In VillinCreERT2;MYO5BF/F distal small intestine, most
DPPIV was retained on the apical membrane with a small
subset of internalized DPPIV found in the small vesicles
(asterisk). As in the duodenum, this internalized DPPIV pop-
ulation co-labeled with Lamp2 (asterisk). Scale bar: 25 mm.
SI, small intestine.
Figure 19. Disruption of apical and basolateral trafﬁcking in VillinCreERT2;MYO5BF/F mice. (A) Control and Villin-
CreERT2;MYO5BF/F duodenum was stained for an apical exchanger protein (NHE3) and for apical trafﬁcking proteins (Rab8a
and Rab11a). The normal apical localization of NHE3 (top left panel) found in control duodenum was collapsed to a diffuse
pattern in the cytoplasm in VillinCreERT2;MYO5BF/F duodenum (green asterisk). Correspondingly, the normal concentrated
subapical localization of Rab8a and Rab11a was disrupted in VillinCreERT2;MYO5BF/F duodenum (green asterisks). In Vil-
linCreERT2;MYO5BF/F duodenum, Rab8a and Rab11a was prominently lost from the subapical region and diverted to a very
diffuse cytoplasmic localization. Scale bar: 50 mm. (B) Basolateral trafﬁcking was analyzed by immunostains for Na/K-
ATPase, E-cadherin, and p120 in control and VillinCreERT2;MYO5BF/F duodenum. In control duodenum, all 3 proteins
were tightly localized to the basolateral membrane of enterocytes. Although some normal basolateral localization was
retained in VillinCreERT2;MYO5BF/F duodenum, aberrant small internal punctate vesicles also were observed for Na/K-
ATPase, E-cadherin, and p120 (green asterisks and insets), suggesting that loss of MYO5B disrupts basolateral traf-
ﬁcking. Scale bar: 50 mm.
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Hyperproliferation
VillinCreERT2;MYO5BF/F duodenum sections were
immunostained for Ki67 to examine the effect of MYO5B
loss on crypt cells. A signiﬁcant increase in proliferating
cells within VillinCreERT2;MYO5BF/F crypts was observed
as compared with control crypts (22 cells per crypt to 15
cells per crypt, respectively) (Figure 20F and G). These
ﬁndings resembled the hyperproliferation observed in
germline MYO5B KO mice. No proliferating cells were
observed outside of crypts in VillinCreERT2;MYO5BF/F
duodenum.Induced MYO5B Loss in VillinCreERT2;MYO5BF/F
Neonates Causes Microvillus Inclusion Formation
Together, our studies of both neonate and adult MYO5B
loss suggest that the neonatal duodenum is primed for
microvillus inclusion formation, consistent with the relative
absence of inclusions after induction of MYO5B loss
in adults. To test this hypothesis, we induced MYO5B loss in
2-day-old VillinCreERT2;MYO5BF/F and killed the neonates 3
days later (the same timeline used in adult Villin-
CreERT2;MYO5BF/F mouse studies). MYO5B loss was ach-
ieved in the bottom portion of most villi (Figure 21). As seen
in the other neonatal MYO5B loss models as well as in
March 2016 Mouse Models of MYO5B Knockout 153VillinCreERT2;MYO5BF/F adult mice, DPPIV was mislocalized
to a diffuse subapical region upon MYO5B loss (Figure 21).
Ezrin immunostaining also showed the development of
numerous ezrin-positive inclusions in the same enterocytes
with DPPIV mislocalization. The number of ezrin-positive
inclusions more closely resembled the results found in the
germline or constitutive VillinCre-directed neonatal MYO5B
KO mice.Discussion
The present results suggest that the microvillus in-
clusions associated with loss of functional MYO5B are not
central to the pathologic symptoms of microvillus inclusion
disease. Thus, induction of MYO5B loss in adult mice led to
rapid development of diarrhea, but did not induce the for-
mation of signiﬁcant numbers of microvillus inclusions.
Nevertheless, germline and constitutive targeted knockout
of MYO5B did show clear microvillus inclusion formation in
the duodenum. In addition, in conditional KO mice induced
at 2 days of age, we also observed formation of a prominent
number of inclusions in the duodenum. It therefore appears
likely that the deletion of MYO5B in the neonatal period has
exposed a critical apical membrane internalization para-
digm that is speciﬁcally active in the neonatal period. The
most likely pathway shown would be an apical macro-
pinocytotic route, as we previously showed in CaCo2–BBE
cells.9 Internalization and transcytosis of maternal IgGs in
the neonatal period is a critical process for immune pro-
tection of newborns.23 Previous investigations in rats have
noted that this pathway is substantially down-regulated
after weaning.24 The relative absence of microvillus in-
clusions in conditional allele mice induced at 8 weeks of age
suggests that this apical macropinocytotic pathway is abol-
ished after the neonatal period. Importantly, we have shown
here that microvillus inclusions in MYO5B germline
knockout mice contained IgG. During the neonatal period,
this apical macropinocytotic route may complement the
previously described internalization pathways that may
provide for ongoing IgG internalization in the distal intestine
and after weaning.25 These ﬁndings support the origin of
microvillus inclusions as macropinocytotic events and
electron micrographs show the formation of the inclusionsFigure 20. (See previous page). Proliferation and EM analys
control duodenum showed long and straight microvilli on the
analysis, VillinCreERT2;MYO5BF/F duodenum showed varying ab
apical microvilli (left panel) were observed as well as patches of
The length and width of apical microvilli from control and Villi
VillinCreERT2;MYO5BF/F duodenal enterocytes, microvilli that wer
addition, apical microvilli were also wider in VillinCreERT2;MYO5
examined by SEM showed tightly packed microvilli. Scale bar
visualized in VillinCreERT2;MYO5BF/F duodenum, as were areas o
SEM analysis of some cross-sectioned enterocytes further conﬁ
as well as showed aberrant microvilli morphology such as a
Proliferation in control and VillinCreERT2;MYO5BF/F duodenu
phenylindole (DAPI) (blue) immunoﬂuorescence. Proliferation (n
in both control and VillinCreERT2;MYO5BF/F duodenum. Scale ba
quantiﬁed for comparison. A signiﬁcant increase in prolifera
compared with control duodenal crypts. *P ¼ .05.from invaginations of the apical membrane. Our previous
studies in CaCo2–BBE cell MYO5B knockdown and restitu-
tion studies have shown the origin of microvillus inclusions
from internalization of the apical membrane.9 Interestingly,
previous studies have shown that FcRN internalization of
IgG in CaCo2 cells occurs through an apical internalization
pathway most consistent with macropinocytosis.26 All of
these results suggest that the presence of microvillus in-
clusions reﬂects internalization of apical membranes in
neonatal duodenal enterocytes. The manifestation of the
inclusions therefore would represent a failure of enter-
ocytes to recycle these membranes through a MYO5B and
Rab11a-dependent process, as previously observed in
CaCo2 cells.9 Indeed, while this manuscript was under re-
view, Vogel et al27 provided further detail of the deﬁcits in
Rab11a- and Rab8a-mediated apical recycling in CaCo2 cells
with gene editing–mediated loss of MYO5B.
Although microvillus inclusions may not account for the
pathology of diarrheal disease, it appears more likely that
symptoms accrue from deﬁcits in apical delivery or main-
tenance of critical transporters and enzymes in the micro-
villar brush border. As we have described previously in both
Navajo MVID patients and MYO5B CaCo2–BBE knockdown
lines,9 DPPIV was observed prominently in Lamp2-positive
lysosomes in the MYO5B knockout mouse models. This
phenotype was present in both germline mice and in adult
mice with induced intestinal knockout. Also as in previous
studies,11,17 we found dispersal of the normal subapical
localization of both Rab8a and Rab11a. These results appear
compatible with a failure to execute appropriate recycling of
apical membrane constituents and their eventual shunting
to the lysosomes for degradation. An absence of apical
transporters such as NHE3 or sodium glucose cotransporter
1 could account for the severe diarrhea.
While this manuscript was in preparation, 2 other
groups reported mouse models for MYO5B deletion. Carton-
Garcia et al10 reported a germline gene-trap knockout
mouse for MYO5B. These mice died during their ﬁrst day of
life. As seen in our studies, they developed microvillus in-
clusions in the duodenum. This early death for the mice
made further detailed analysis difﬁcult. We were unable to
produce viable germline offspring on a pure C57BL/6
background, and this seems to correlate with the ﬁndings inis of VillinCreERT2;MYO5BF/F duodenum. (A) TEM images of
apical surface of enterocytes. Scale bar: 2 mm. (B) By TEM
errations in the apical microvilli. Frequent areas of shortened
apical microvilli denudation (right panel). Scale bar: 2 mm. (C)
nCreERT2;MYO5BF/F duodenal enterocytes was quantiﬁed. In
e observed were signiﬁcantly shorter than control microvilli. In
BF/F duodenal enterocytes. *P < .05. (D) Control duodenum
: 2 mm. (E) By SEM, areas of tightly packed microvilli were
f shortened microvilli. Scale bar: 2 mm (left panel). In addition,
rmed areas of short microvilli (top right panel; scale bar: 1 mm)
linked appearance (bottom right panel; scale bar: 1 mm). (F)
m was examined via Ki67 (green) and 40,6-diamidino-2-
oted by Ki67 immunoreactivity) was restricted to the crypts
r: 50 mm. (G) The number of Ki67-positive cells per crypt was
tion was seen in VillinCreERT2;MYO5BF/F duodenal crypts
Figure 21. Neonatal induction of MYO5B loss in VillinCreERT2;MYO5BF/F mice. Tamoxifen-induced MYO5B loss in 2-day-
old littermates of controls (top row and second inset row) and VillinCreERT2;MYO5BF/F mice (third row and bottom inset row)
was examined to analyze the formation of microvillus inclusions in neonates as compared with adult VillinCreERT2;MYO5BF/F
mice. Sections of duodenum were triple-stained for MYO5B (blue), DPPIV (green), and ezrin (red). In controls, MYO5B localized
to the subapical region just below the DPPIV and ezrin-positive co-labeled brush border. Some diffuse internal DPPIV is
observed in controls (asterisk). In VillinCreERT2;MYO5BF/F neonatal duodenum, the prominent MYO5B subapical localization
was lost in the bottom portion of villi. Of note, MYO5B was not completely lost from the upper half of villi. DPPIV was lost from
the apical membrane and collapsed into a prominent, diffuse subapical region (asterisk). Furthermore, in contrast to adult
VillinCreERT2;MYO5BF/F mice, VillinCreERT2;MYO5BF/F neonates formed numerous internal ezrin-positive inclusions in the
duodenum (arrowheads) that co-labeled with DPPIV. These inclusions resemble the microvillus inclusions found in in MYO5B
KO and VillinCre;MYO5BF/F neonatal mice. Scale bar: 50 mm.
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March 2016 Mouse Models of MYO5B Knockout 155these gene-trap knockouts. With breeding onto the outbred
CD1 strain, we were able to extend survival to approxi-
mately a week while preserving the MVID phenotype.
Schneeberger et al11 recently reported an inducible intes-
tinally targeted MYO5B deletion mouse based on the Vil-
linCreERT2 driver and a fourth exon ﬂoxed allele. Many of the
ﬁndings were similar to those we reported here, including
induction of diarrhea, timing of loss of apical transporters,
and alterations in apical and basolateral trafﬁcking. Never-
theless, the report appears to differ from our ﬁndings on
prevalence of microvillus inclusions after induction of
MYO5B KO in adult mice. It seems likely that the numbers of
inclusions in this previous investigation may have been
overestimated because of a lack of comparison with either
induction in neonatal mice or germline or constitutive KO
mice. In addition, the absolute numbers of inclusions may
vary in inducible mice based on strain differences and the
exact time of induction vs the transition to adolescence after
weaning, a time when one would expect to see a down-
regulation of apical macropinocytosis owing to the cessa-
tion of breast feeding. The predominance of ﬁndings in our
studies suggests that formation of microvillus inclusions in
duodenal enterocytes is far more pronounced in neonates.
Our results in the MYO5B knockout strains also show
that the manifestations of pathologic changes are region
dependent. The previous reports in germline gene-trap and
adult inducible MYO5B KO did not comment on regional
differences within the small intestine.10,11 As one might
expect for a mechanism involved in apical internalization of
maternal IgG, the microvillus inclusions in both germline
and VillinCre;MYO5BF/F mice were predominant in the du-
odenum and proximal jejunum and essentially were absent
in the ileum and colon. Previous investigations have noted
microvillus inclusions are less frequent in the colonocytes of
MVID patients.28 In the germline and constitutive intestinal
knockout mice, we also observed less prominent changes in
apical transporters in the ileum. These ﬁndings indicate that
the diarrheal phenotype may accrue predominantly from a
duodenal deﬁcit in absorption. Previous investigations have
documented various differences in the physiology of duo-
denum, jejunum, and ileum.29 Most notably, in studies of
massive small-bowel resection, the ileum has a higher ca-
pacity to hypertrophy.30 This phenomenon often is critical
for the recovery of function in babies with short-gut syn-
drome.31 If our ﬁndings in mice can be corroborated in
children with MVID, then MVID diarrhea may be amenable
to treatment with strategies for exclusion of the duodenum
and promotion of ileal adaptation.
It is important to note that the MYO5B knockout mice
did not recapitulate a number of the phenotypic changes
usually associated with MVID.9 First of all, we did not
observe complete loss of microvilli in germline knockouts
and VillinCre;MYO5BF/F mice. Rather these mice showed an
intact brush border with short microvilli. These ﬁndings are
in agreement with those in the MYO5B gene-trap KO
model.10 This microvillar phenotype is similar to that
observed in Rab11a knockout mice.17,18 Interestingly, in the
tamoxifen-induced VillinCreERT2;MYO5BF/F mice, we did
observe microvillar denudation in some cells. A similarphenomenon also was reported by Schneeberger et al11 in
inducible MYO5B KO adult mice. Some of these differences
may be owing to age-dependent observations. In the
germline KO mouse models, observations were focused on
mice in their ﬁrst week of life, whereas the inducible mice
essentially were adults. Similarly, human MVID children
often do not undergo a biopsy until their third month of life.
In addition, MVID children have usually spent weeks on
total parenteral nutrition without luminal alimentation. A
lack of luminal alimentation usually is associated with
varying levels of villus atrophy.32–34 Thus, the intestinal
phenotype observed in MVID patients in their second or
third month of life would reﬂect a combination of changes
from the genetic disease along with the impact of extended
bowel rest. We also did not observe the gross changes in
junctional proteins such as E-cadherin in the germline and
targeted knockout mice, so these more prominent losses in
epithelial polarity observed in MVID children may reﬂect
ramiﬁcations between disease and the lack of alimentation.
Indeed, loss of E-cadherin was observed in a mouse model
of total parenteral nutrition.35 Alternatively, it is possible
that dominant-negative mutations, such as the P660L
MYO5B mutation in the Navajo, elicit a stronger phenotype
than the knockout. The pathology in true human MYO5B
knockouts has not been evaluated in depth. It also is notable
that we did not observe any signiﬁcant impact on the liver
in germline knockouts. Similar results have been reported
recently in the gene-trap MYO5B knockout mouse.10 Liver
disease in MVID patients has been noted previously as quite
variable.36 Early in vitro studies suggested that MYO5B was
critical for proper assembly and function of the liver bile
canaliculus.37 However, liver disease in MVID patients may
reﬂect an effect of extended parenteral nutrition from birth
or a more subtle genetic deﬁcit that is ampliﬁed in the
presence of parenteral nutrition by MYO5B loss.
In summary, we have examined the effects of MYO5B
loss in 3 separate mouse models reﬂecting germline dele-
tion, constitutive intestinal deletion, and inducible intestinal
deletion in both adults and neonates. Our ﬁndings show that
microvillus inclusions are an indicator of MYO5B loss and
likely reﬂect inhibition of recycling out of apical macro-
pinosomes in the enterocytes of the proximal small intes-
tine. Thus, this mutation has shown a previously
unrecognized process operating in neonatal duodenal
enterocytes. Nevertheless, our ﬁndings support the concept
that the true pathology of the disease is manifested in the
loss of proper trafﬁcking and recycling of transporters to
the apical brush border in enterocytes.9,27 Our ﬁndings
suggest that these apical transporters are diverted promi-
nently to degradation pathways in the lysosome. Thus,
treatment of MVID must focus on re-establishment of
proper recycling, replacement of diseased enterocytes, or
facilitation of mechanisms that still may be operable for
distal intestine adaptation.References
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